WE CARE ABOUT YOUR HEALTH

Bringing quality & affordable healthcare within the reach of common people

Recent updates / news
  • Blood vessel-on-a-chips show anti-cancer

    Researchers at the Institute of Industrial Science (IIS), the University of Tokyo, CNRS and INSERM, report a new organ-on-a-chip technology for the study of blood vessel formation and drugs targeting. The technology recreates a human blood vessel and shows how new capillaries grow from a single vessel (parent vessel) in response to proper biochemical signaling cues. The technology can further be used to develop drugs targeting this growth as a therapeutic approach to treat cancer and blood-vessel-related diseases.

  • AI 'scientist' finds that toothpaste ingredient may help fight drug-resistant malaria

    An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of malaria parasite that have grown resistant to one of the currently-used drugs. This discovery, led by researchers at the University of Cambridge, was aided by Eve, an artificially-intelligent 'robot scientist'.

  • NHS plans to be first to eliminate hepatitis C

    NHS England has laid out plans for England to become the first country to eliminate hepatitis C, at least five years earlier than the World Health Organisation's target date of 2030.

  • First-line use of lung cancer drug Zykadia gets NHS nod

    Final guidelines have now been published endorsing NHS use of Novartis' Zykadia as a first line of attack for anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), offering patients a new treatment option.

  • Research backs blanket screening for breast, ovarian cancer mutations

    Research led by Queen Mary University of London has concluded that whole-population testing for mutations linked with a higher risk of breast and ovarian cancer is cost-effective.

  • Procedure Beats Drugs for A-Fib With Heart Failure

    For people with both atrial fibrillation and heart failure, a procedure called ablation can be life-saving, a new clinical trial shows.

Recent products

ACEHICARE-P

ACEHICARE-SP

ACEHICARE-TH

RABHICARE-ISR

HBHICARE

CALHICARE

ETOHICARE-TH 4

TRAMPCARE

ULTIGABA

LINOCARE-600

LINOCARE-plus

SHEILDCORT-1

ETOHICARE-TH 4

Our products

ACEHICARE-P
ACEHICARE-SP
ACEHICARE-TH
RABHICARE-ISR
HBHICARE
CALHICARE
ETOHICARE-TH 4
TRAMPCARE
ULTIGABA-M
LINOCARE-600
LINOCARE-plus
SHEILDCORT-1
ETOHICARE-PH 4

ABOUT US

In the process of launching many innovative healthcare products of international standards

HIGHCARE pharma headquartered at Mumbai is a Indian pharmaceutical company dealing into multi dimensional range of pharmaceutical products. Our medicines are highly reliable and recommended by medical practitioners.

HCP dedicated to deliver branded healthcare products and also committed to proficient in human health care by setting international standards.

HCP trusted by healthcare professionals and patients.

HISTORY

In the process of launching many innovative healthcare products of international standards
VISION

To be the most admired health care pharma company in india committed to bringing innovative products & product line extension.

MISSION

We will discover, develop & successfully market pharmaceutical product to prevent, diagnose, alleviate & cure diseases.

OUR VALUES
  • Knowledge

    We aspire to do things creatively.

  • Action

    We are consistent in our thought, speech & action.

  • Case

    Trustship : We protect and enhance the interest of our customers, community employees, partners and shareholders.

  • Impact

    Performance : We strive to achieve market leadership in scale & profitability whereas we compete.

CAREERS

Join Us

We are hiring pharma professional, get in touch with us by sending your updated resume to care@highcarepharma.com